Kylie Jenner gets happy – CBD-Intel’s weekly round-up of business snippets includes items from the US, Canada, Ireland and Australia
A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease. The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and US-based pharmaceutical-grade medical cannabis producer AXIM Biotechnologies.
CBD vaping stakeholders in Europe expect to see the category continue to grow – fuelled by unclear regulations over CBD as a food ingredient combined with a low barrier to entry
The latest news and developments in the CBD industry worldwide rounded up in CBD-Intel’s weekly News In Brief.
The sports world is becoming increasingly enamoured with CBD. US professional golfers have become the latest sporting personalities to endorse CBD products, including 2009 US Open winner Lucas Glover.
Will CBD continue to wind its way into the professional sporting arena in the US and Canada – and even further afield?
Interest and investment in CBD beverages continues to grow despite some criticism of cannabis drinks in general; so far, the industry has struggled to get oil-based cannabinoids into water-based beverages without issues. But all of that is changing, rapidly…
CBD manufacturers could and should look at using a fermentation process to extract cannabidiol, a new report suggests
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up, bringing updates from the US, Canada, London, Hungary, Spain, Google and Facebook
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up, bringing updates from the US, Canada, Germany, South America and southern Africa
Recent studies show cannabinoids could help with sleep disorders, obsessive compulsive disorder (OCD), and cocaine addiction, while genetic research could help regulators delineate between cannabis strains
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
Sales of water infused with cannabidiol (CBD) have surged in the US, but a range of regulatory and other obstacles in Europe may tamp down its popularity among Europeans. Some producers in Europe have gone so far as to call CBD water a “scam” that offers consumers almost none of the promised benefits. CBD water […]
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
CBD-Intel News in Brief from the US, Canada and UK
Investments made by Turning Point Brands in a CBD extraction company were based on misleading information, a lawsuit filed in a US court alleges
A new hemp extraction facility, said to be the largest in Europe, has opened in the Sicilian province of Ragusa for the production of CBD-containing products such as oils, cosmetics, and pharmaceuticals
Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
Hemp plants in Italy used for the production of CBD are being grown in buildings heated with biofuel
A Swiss CBD company claims to have become the first cannabidiol firm to use liposomes to deliver the substance into users’ bodies and says its new products will deliver CBD to a user’s system four times faster than others
A British biopharmaceutical company will be trialling the use of CBD and other hemp-based products for treating opioid addiction, as well as other conditions
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Companies which make beverages containing CBD are resorting to new technologies to get around a thorny problem.
CBD is not water soluble, meaning a fatty emulsion needs to be created in order to get the substance to mix with a liquid – but canny companies are using a process called nanemulsion, where the molecule sizes are reduced to enable the CBD to mix better with the drink.
Among a wave of drinkable CBD products released in the UK this year, one of the more controversial is Love Hemp’s CBD-infused bottled water – advertised as being spring water “infused with CBD hemp droplets”
Two Canadian companies with interests in CBD have announced investments in major Italian legal cannabis producers
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
A Big Tobacco company which invested in a medical cannabis startup will not influence how the smaller firm is run, according to bosses at Oxford Cannabinoid Technologies
Two North American companies have announced collaborations with established drug delivery firms to produce and expand distribution for oral CBD strips – soluble strips that dissolve in the mouth
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say
Canadian company Emerald Health Therapeutics is set to sign a deal to use an extraction facility capable of processing 1000 tonnes of biomass to produce 600m softgel CBD capsules a year
Intrexon, an American biotech company listed on the Nasdaq stock exchange, has announced a development in its microbial platform capable of producing cannabinoids for medical use
Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms in a partnership between a Canadian and a US company
The town of Nelas in north central Portugal is to be the site of a new CBD oil factory producing medicinal products extracted from cannabis sativa for export to America and within Europe
Vaping businesses in the US are experiencing a shift in consumer preferences for methods of extracting CBD and THC from cannabis, with more manufacturers developing distillers to help meet the growing demand for purer products
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use
E-cigarette firms who already have devices on the market are manoeuvring to see how their products can serve the growing marijuana industry – and they face competition there from some well-financed start-ups.
39 U.S. states and the District of Columbia have laws that legalise and/or decriminalise marijuana use or possession to various extents. E-cig companies are well positioned to enter the emerging marijuana market because of their technical expertise and intimate knowledge of the science behind vaporisers, and several types of cannabis-compatible vaporisers, or “c-cigs”, may succeed in the U.S. market.
Start your FREE trial
Sign up to access to our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.